[HTML][HTML] Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
Despite advances in prostate cancer diagnosis and management, morbidity from prostate
cancer remains high. Approximately 20% of men present with advanced or metastatic …
cancer remains high. Approximately 20% of men present with advanced or metastatic …
Autophagy—a key player in cellular and body metabolism
KH Kim, MS Lee - Nature Reviews Endocrinology, 2014 - nature.com
Abstract Knowledge gained over the past 10 years about the mechanisms that underpin
autophagy has provided a universal framework for studies of diverse physiological and …
autophagy has provided a universal framework for studies of diverse physiological and …
A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma …
MR Rosenfeld, X Ye, JG Supko, S Desideri… - Autophagy, 2014 - Taylor & Francis
Preclinical studies indicate autophagy inhibition with hydroxychloroquine (HCQ) can
augment the efficacy of DNA-damaging therapy. The primary objective of this trial was to …
augment the efficacy of DNA-damaging therapy. The primary objective of this trial was to …
Quercetin shows anti‐tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway
L Wu, J Li, T Liu, S Li, J Feng, Q Yu, J Zhang… - Cancer …, 2019 - Wiley Online Library
Objective Hepatocellular carcinima is one of the most common tumors in clinic and also one
of the leading causes of death from cancer worldwide. Quercetin shows significant effects on …
of the leading causes of death from cancer worldwide. Quercetin shows significant effects on …
Regulation of autophagy by coordinated action of mTORC1 and protein phosphatase 2A
PM Wong, Y Feng, J Wang, R Shi, X Jiang - Nature communications, 2015 - nature.com
Autophagy is a cellular catabolic process critical for cell viability and homoeostasis.
Inhibition of mammalian target of rapamycin (mTOR) complex-1 (mTORC1) activates …
Inhibition of mammalian target of rapamycin (mTOR) complex-1 (mTORC1) activates …
Rationally designed rapamycin-encapsulated ZIF-8 nanosystem for overcoming chemotherapy resistance
M Xu, Y Hu, W Ding, F Li, J Lin, M Wu, J Wu, LP Wen… - Biomaterials, 2020 - Elsevier
Abstract Zeolitic imidazolate framework-8 (ZIF-8) nanoparticles are widely reported as a pH-
sensitive drug delivery carrier with high loading capacity for tumor therapy. However, the …
sensitive drug delivery carrier with high loading capacity for tumor therapy. However, the …
Autophagy regulation and its role in cancer
The modulation of macroautophagy is now recognized as one of the hallmarks of cancer
cells. There is accumulating evidence that autophagy plays a role in the various stages of …
cells. There is accumulating evidence that autophagy plays a role in the various stages of …
Novel insights into autophagy and prostate cancer: a comprehensive review
D Loizzo, SD Pandolfo, D Rogers, C Cerrato… - International Journal of …, 2022 - mdpi.com
Autophagy is a complex process involved in several cell activities, including tissue growth,
differentiation, metabolic modulation, and cancer development. In prostate cancer …
differentiation, metabolic modulation, and cancer development. In prostate cancer …
Autophagy as a modulator and target in prostate cancer
JM Farrow, JC Yang, CP Evans - Nature reviews Urology, 2014 - nature.com
Abstract Autophagy, or'self-eating', is an adaptive process that enables cells to cope with
metabolic, toxic, and even infectious stressors. Although the adaptive capability of …
metabolic, toxic, and even infectious stressors. Although the adaptive capability of …
Identification of secreted proteins that reflect autophagy dynamics within tumor cells
Macroautophagy, a catabolic process of cellular self-digestion, is an important tumor cell
survival mechanism and a potential target in antineoplastic therapies. Recent discoveries …
survival mechanism and a potential target in antineoplastic therapies. Recent discoveries …